Reframing Steroid Therapy in Neuromuscular Disease: Vamorolone and LIONHEART

In this epiosde, Carol Wittlieb-Weber, MD, provides a cardiology-focused look at why vamorolone’s dissociative steroid profile and mineralocorticoid receptor antagonism may matter for cardiac fibrosis and remodeling in DMD.

In this segment, Wittlieb-Leber examines how vamorolone trials address long-standing questions about steroid exposure, cardiac risk, and meaningful cardiac endpoints in Duchenne.

A forward-looking discussion on cardiac monitoring strategies, real-world data, and how vamorolone may apply across Duchenne and Becker muscular dystrophy.